• 1
    Lowe, J.E., Sellers, A.F. and Brondum, J. (1980) Equine pelvic flexure impaction. A model used to evaluate motor events and compare drug response. Cornell Vet. 70, 401-412.
  • 2
    Kalpravidh, M., Lumb, W.V., Wright, M. and Heath, R.B. (1984) Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies. Am. J. Vet. Res. 45, 217-223.
  • 3
    Jochle, W., Moore, J.N., Brown, J., Baker, G.J., Lowe, J.E., Fubini, S., Reeves, M.J., Watkins, J.P. and White, N.A. (1989) Comparison of detomidine, butorphonal, flunixin meglumine and xylazine in clinical cases of equine colic. Equine Vet. J., Suppl., 7, 111-116.
  • 4
    Clark, J.O. and Clark, T.P. (1999) Analgesia. Vet. Clin. N. Am.: Equine Pract. 15, 705-723.
  • 5
    Tobin, T. (1981) Drugs and the Performance Horse. Charles C. Thomas, Publ., Springfield, Illinois.
  • 6
    Hamm, D., Turchi, P., Johnson, J.C., Lockwood, P.W., Thompson, K.C. and Katz, T. (1997) Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis. Am. J. Vet. Res. 58, 298-302.
  • 7
    Kallings, P., Johnston, C. and Drevemo, S. (1999) Effects of flunixin on movement and performance of standardbred trotters on the track. Equine Vet. J. 30, 270-273.
  • 8
    Erkert, R.S., MacAllister, C.G., Payton, M.E. and Clarke, C.R. (2005) Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixing meglumine in horses with navicular disease. Am. J. Vet. Res. 66, 284-288.
  • 9
    Keegan, K.G., Messer, N.T., Reed, S.K., Wilson, D.A. and Kramer, J. (2008) Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. Am. J. Vet. Res. 69, 167-173.
  • 10
    Foreman, J.H., Grubb, T.L., Inoue, O.J., Banner, S.E. and Ball, K.T. (2010) Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during, and after exercise in an experimental reversible model of foot lameness in horses. Equine Vet. J., Suppl., 38, 601-605.
  • 11
    Foreman, J.H. and Ruemmler, R. (2011) Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. Equine Vet. J. Suppl., 40, 12-17.
  • 12
    Foreman, J.H. and Lawrence, L.M. (1987) Lameness and heart rate elevation in the exercising horse. Proc. Equine Nutr. Physiol. Symp. 10, 339-344.
  • 13
    Foreman, J.H., Grubb, T.L. and Inoue, O.J. (1994) Comparison of the effects of flunixin meglumine and ketoprofen on experimentally-induced lameness in the horse. Proc. Am. Ass. Equine Practnrs. 40, 51.
  • 14
    Thomas, K.K. (2002) Physiological Effects of Perineural Mepivacaine Anesthesia and Topical Perineural Capsaicin in a Reversible Model of Equine Foot Lameness, University of Illinois, Urbana, Illinois.
  • 15
    Seino, K.K., Foreman, J.H., Greene, S.A., Goetz, T.E. and Benson, G.J. (2003) Effects of topical perineural capsaicin in a reversible model of equine foot lameness. J. Vet. Intern. Med. 17, 563-566.
  • 16
    Foreman, J.H., Barange, A., Lawrence, L.M. and Hungerford, L.L. (2008) Effects of single-dose intravenous phenylbutazone on experimentally-induced, reversible lameness in the horse. J. Vet. Pharmacol. Ther. 31, 39-44.
  • 17
    Foreman, J.H., Bayly, W.M., Grant, B.D. and Gollnick, P.D. (1990) Standardized exercise test and daily heart rate responses of Thoroughbred horses to conventional race training. Am. J. Vet. Res. 50, 914-920.
  • 18
    Goetz, T.E. and Comstock, C. (1985) The use of the adjustable heart bar shoe in the treatment of laminitis in horses. Proc. Am. Ass. Equine Practnrs. 31, 605-616.
  • 19
    Semrad, S.D., Hardee, G.E., Hardee, M.M. and Moore, J.N. (1985) Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. Am. J. Vet. Res. 46, 2474-2479.
  • 20
    Semrad, S.D. and Moore, J.N. (1987) Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horse. Prostaglandins Leukot. Med. 27, 169-181.
  • 21
    Semrad, S.D., Hardee, G.E., Hardee, M.M. and Moore, J.N. (1987) Low dose flunixin meglumine: effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. Equine Vet. J. 19, 201-206.
  • 22
    Snow, D.H., Bogan, J.A., Douglas, T.A. and Thompson, H. (1979) Phenylbutazone toxicity in ponies. Vet. Rec. 105, 26-30.
  • 23
    Snow, D.H., Douglas, T.A., Thompson, H., Parkins, J.J. and Holmes, P.H. (1981) Phenylbutazone toxicosis in ponies. (1980). Vet. Rec. 106, 68.
  • 24
    Snow, D.H., Douglas, T.A., Thompson, H., Parkins, J.J. and Holmes, P.H. (1981) Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study. Am. J. Vet. Res. 42, 1754-1759.
  • 25
    Traub, J.L., Gallina, A.M., Grant, B.D., Reed, S.M., Gavin, P.R. and Paulsen, L.M. (1983) Phenylbutazone toxicosis in the foal. Am. J. Vet. Res. 44, 1410-1418.
  • 26
    Collins, L.G. and Tyler, D.E. (1985) Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E2. Am. J. Vet. Res. 46, 1605-1615.
  • 27
    MacAllister, C.G., Morgan, S.J., Borne, A.T. and Pollet, R.A. (1993) Effects of large doses of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J. Am. Vet. Med. Ass. 202, 71-77.
  • 28
    Reed, S.K., Messer, N.T., Tessman, R.K. and Keegan, K.G. (2006) Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am. J. Vet. Res. 67, 398-402.